1. Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3. Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
4. Market Dynamics
4.1. Drivers
4.1.1. Increasing prevalence of cancer and infectious diseases
4.1.2. Rising demand for protein production
4.1.3. Advent of the biopharmaceutical market
4.1.4. Rise in R&D in the field of cell-based therapies
4.1.5. Government and top player’s investments
4.2. Restraints
4.2.1. Expensive transfection technology instruments
4.2.2. High risk with the cells of adverse reactions
4.3. Opportunities
4.3.1. Advancements in Stem cell therapy, and Gene therapy
4.4. Challenges
4.4.1. Need of disruptive technologies to address transfection in hard-to-transfect cells
5. Global Transfection Technologies Market– By Method
5.1. Instrument-Based Methods
5.1.1. Electroporation
5.1.2. Microinjection
5.1.3. Laserfection
5.1.4. Biolistic Technology
5.2. Reagent-Based Methods
5.2.1. Lipofection (Lipid Mediated Transfection)
5.2.2. Calcium Phosphate
5.2.3. Cationic Polymers
5.2.4. Activated Dendrimers
5.2.5. DEAE dextran
5.2.6. Magnetic Beads (Magnet-mediated Transfection)
5.3. Virus-Based Methods
6. Global Transfection Technologies Market– By Application
6.1. Bio-Medical Research
6.2. Cancer Research
6.3. Transgenic Models
6.4. Gene and Protein Expression Studies
6.5. Therapeutic Delivery
6.5.1. Biotherapeutics
6.5.2. Electro-chemotherapy and Electro-immunotherapy
6.6. Protein Production
6.7. Cell-Based Microarray for Drug Discovery and Development
7. Global Transfection Technologies Market- By End-users
7.1. Hospitals
7.2. Clinics
7.3. Pharmaceutical & Biotechnology Companies
7.4. Others
8. Global Transfection Technologies Market– By Geography
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.3. Europe
8.3.1. U.K.
8.3.2. Germany
8.3.3. France
8.3.4. Italy
8.3.5. Spain
8.3.6. Russia
8.3.7. Others
8.4. APAC
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. Australia & New Zealand
8.4.5. South Korea
8.4.6. Others
8.5. South America
8.5.1. Brazil
8.5.2. Argentina
8.5.3. Others
8.6. Middle East & Africa
8.6.1. Middle East
8.6.2. Africa
9. Global Transfection Technologies Market– Company Profiles
9.1. Bio-Rad Laboratories Inc.
9.2. Polyplus Transfection
9.3. Promega Corporation
9.4. Thermo Fisher Scientific
9.5. Lonza Group
9.6. MaxCyte Inc.
9.7. Agilent Technologies
9.8. Qiagen
9.9. Boca Scientific Inc.
9.10. Roche Holding AG
9.11. Altogen Biosystems
9.12. Sigma-Aldrich
9.13. SignaGen Laboratories
9.14. Promo Cell GmbH
10. Global Transfection Technologies Market- Competitive Landscape
10.1. Market Share Analysis
10.2. Strategies Adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
11. Market Insights
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
12. Appendix
12.1. List of tables
12.2. List of figures
